Hydrolyzed Protein Formula for Allergy Prevention in Preterm Infants: Follow-Up Analysis of a Randomized, Triple-Blind, Placebo-Controlled Study

Background: Allergic diseases are a major public health burden worldwide. Evidence suggests that early nutrition might play a key role in the future development of allergies and the use of hydrolyzed protein formulas have been proposed to prevent allergic disease, mainly in term infants with risk fa...

Full description

Saved in:
Bibliographic Details
Main Authors: Antonio Di Mauro (Author), Maria Elisabetta Baldassarre (Author), Giulia Brindisi (Author), Anna Maria Zicari (Author), Martina Tarantini (Author), Nicla Laera (Author), Manuela Capozza (Author), Raffaella Panza (Author), Silvia Salvatore (Author), Licia Pensabene (Author), Margherita Fanelli (Author), Nicola Laforgia (Author)
Format: Book
Published: Frontiers Media S.A., 2020-07-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_1cb3449fffda4e24b86dc23f232fb5c5
042 |a dc 
100 1 0 |a Antonio Di Mauro  |e author 
700 1 0 |a Maria Elisabetta Baldassarre  |e author 
700 1 0 |a Giulia Brindisi  |e author 
700 1 0 |a Anna Maria Zicari  |e author 
700 1 0 |a Martina Tarantini  |e author 
700 1 0 |a Nicla Laera  |e author 
700 1 0 |a Manuela Capozza  |e author 
700 1 0 |a Raffaella Panza  |e author 
700 1 0 |a Silvia Salvatore  |e author 
700 1 0 |a Licia Pensabene  |e author 
700 1 0 |a Margherita Fanelli  |e author 
700 1 0 |a Nicola Laforgia  |e author 
245 0 0 |a Hydrolyzed Protein Formula for Allergy Prevention in Preterm Infants: Follow-Up Analysis of a Randomized, Triple-Blind, Placebo-Controlled Study 
260 |b Frontiers Media S.A.,   |c 2020-07-01T00:00:00Z. 
500 |a 2296-2360 
500 |a 10.3389/fped.2020.00422 
520 |a Background: Allergic diseases are a major public health burden worldwide. Evidence suggests that early nutrition might play a key role in the future development of allergies and the use of hydrolyzed protein formulas have been proposed to prevent allergic disease, mainly in term infants with risk factors.Aim: To evaluate the preventive effect of a hydrolyzed protein formula vs. an intact protein formula on allergy development in preterm infants with or without risk factors.Methods: We performed a 3-year follow-up study of a previous triple-blind, placebo-controlled randomized trial. Evidence of atopic dermatitis, asthma and IgE-mediated food allergies were evaluated according to a validated parental questionnaire (Comprehensive Early Childhood Allergy Questionnaire). Food sensitization was also investigated by skin prick test at 3 years of chronological age.Results: Of the 30 subjects in the intact protein formula group and 30 in the extensively hydrolyzed formula group, respectively 18 and 16 completed the 3-year follow-up and entered the final analysis. No group differences in the incidence of atopic dermatitis, asthma, IgE-mediated food allergies, and food sensitization were found.Conclusion: Despite the small number of cases, extensively hydrolyzed protein formula seems to be ineffective in allergic diseases prevention in preterm neonates. Further adequately powered, randomized controlled trials evaluating hydrolyzed protein formula administration to prevent allergic diseases in preterm neonates are needed. 
546 |a EN 
690 |a preterm/full term infants 
690 |a infant formula 
690 |a hydrolyzed protein formula 
690 |a hypersensitivity 
690 |a allergy 
690 |a Pediatrics 
690 |a RJ1-570 
655 7 |a article  |2 local 
786 0 |n Frontiers in Pediatrics, Vol 8 (2020) 
787 0 |n https://www.frontiersin.org/article/10.3389/fped.2020.00422/full 
787 0 |n https://doaj.org/toc/2296-2360 
856 4 1 |u https://doaj.org/article/1cb3449fffda4e24b86dc23f232fb5c5  |z Connect to this object online.